Replies to post #513017 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Have you ever thought about this:

FDA / NIH work to create drugs and then FDA approves them.

NIH dollars sure seem to always find their way to Dr. Liau’s research and to DCVax. NIH and Merck are funding the Keytruda study right now.

Dr. Liau has been the Principal Investigator on several research grants and clinical trials, and her work has been continuously funded by the National Institutes of Health (NIH) for the past 20 years.

“It's the stamp of approval from the NIH, because these types of grants are so rigorously peer-reviewed,” Dr. Liau says. “People get funded based on the strength of the science and that, itself, is very powerful in terms of showing that our research is scientifically valid and meaningful …”

https://www.bentley.edu/news/nih-funded-research-related-every-new-cancer-drug-approved-2010-2016

https://newsroom.ucla.edu/releases/nih-grant-lab-gene-cell-therapies

https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/

https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter

[HyGro]

But yet, the investment community sure doesn't think so - down ~50% in last year AFTER the TLD. Certainly not a positive.